CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $785,000 | -82.2% | 400,000 | +166.7% | 0.02% | -80.5% |
| Q3 2018 | $4,406,000 | -56.1% | 150,000 | -4.9% | 0.12% | -79.4% |
| Q1 2017 | $10,044,000 | +34.8% | 157,754 | -6.0% | 0.57% | +7.9% |
| Q4 2016 | $7,452,000 | +20.5% | 167,754 | -2.2% | 0.53% | +32.8% |
| Q3 2016 | $6,183,000 | +2046.9% | 171,500 | +3237.9% | 0.40% | +1562.5% |
| Q4 2014 | $288,000 | -79.5% | 5,138 | -83.4% | 0.02% | -84.1% |
| Q3 2014 | $1,402,000 | +210.2% | 30,917 | +183.2% | 0.15% | +243.2% |
| Q2 2014 | $452,000 | -96.2% | 10,917 | -93.7% | 0.04% | -96.5% |
| Q1 2014 | $11,929,000 | +547.3% | 172,217 | +463.1% | 1.25% | +467.0% |
| Q4 2013 | $1,843,000 | -92.2% | 30,585 | -92.1% | 0.22% | -77.3% |
| Q3 2013 | $23,676,000 | +151.0% | 389,402 | +176.5% | 0.98% | +2.5% |
| Q2 2013 | $9,433,000 | – | 140,827 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |